07:00 , Jul 13, 2015 |  BC Week In Review  |  Company News

NanoString, Cancer Immunotherapy Trials Network deal

NanoString and the network partnered to discover biomarkers to predict clinical outcomes for cancer immunotherapies. NanoString will use its nCounter Analysis System and PanCancer Immune Profiling technology to analyze blood and tissue biopsies and provide...
08:00 , Nov 12, 2012 |  BC Week In Review  |  Clinical News

CDX-1401: Additional Phase I data

Celldex expects the Cancer Immunotherapy Trials Network (CITN) to begin a trial of CDX-1401 next year, but the company said that the indication and trial design are yet to be determined. The National Cancer Institute...
07:00 , May 23, 2011 |  BC Week In Review  |  Company News

Cytheris cancer news

Cytheris said the Cancer Immunotherapy Trials Network (CITN) selected CYT107 as one of the first candidates for clinical trials. CITN investigators will now submit proposals for trials of CYT107. CITN, which is funded by the...